Perfil
Dr. Shuli Kulak is a Head-Corporate Strategy & Business Development at Solid Biosciences, Inc. Dr. Kulak was previously employed as a Head-Corporate Strategy & Business Development by AavantiBio, Inc. She received her MBA from Sy Syms School of Business and a doctorate degree from Albert Einstein College of Medicine, Inc..
Cargos activos de Shuli Kulak
| Empresas | Cargo | Inicio |
|---|---|---|
| SOLID BIOSCIENCES INC. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Shuli Kulak.
| Empresas | Cargo | Fin |
|---|---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Corporate Officer/Principal | - |
Formación de Shuli Kulak.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Albert Einstein College of Medicine, Inc.
Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sy Syms School of Business
Sy Syms School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
- Bolsa de valores
- Insiders
- Shuli Kulak
















